ARWR (Arrowhead Pharmaceuticals, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ARWR (Arrowhead Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

ARWR

Arrowhead Pharmaceuticals, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Year-End Results
Nov 6, 2025
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
Nov 4, 2025
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Oct 28, 2025
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis
Oct 21, 2025
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
Oct 7, 2025
Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals
Sep 11, 2025
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
Sep 10, 2025
H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR)
Sep 10, 2025
Arrowhead Lands Billion-Dollar Biotech Deal: Stock Soars Double-Digits
Sep 3, 2025
ARWR: Signs Collaboration Agreement with Novartis with $200 Million Upfront…
Sep 2, 2025
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
Sep 2, 2025
Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences
Aug 27, 2025

Reviews